Cipla Usa Inc.
Budesonide
Manufacturer:
Cipla Usa Inc.
Name:
Budesonide
HCPCS Code Descriptor:
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
Category:
J Code
HCPCS:
J7626
NDC(s):
76282-0642-38, 76282-0641-38, 76282-0640-38, 76204-0018-01, 69097-0321-87, 69097-0319-87, 69097-0321-53, 69097-0318-87, 69097-0319-53, 69097-0318-53, 47335-0631-49, 47335-0633-49, 47335-0632-49, 00093-6815-55, 00093-6815-73, 00093-6816-55, 16714-0020-30, 16714-0019-30, 16714-0018-30, 00781-7517-87, 00781-7515-87, 00781-7516-87, 00487-9701-30, 00487-9601-30, 00487-9701-01, 00487-9601-01, 00186-1990-04, 00186-1989-04, 00186-1988-04, 00115-1689-74, 00093-6816-73, 00093-6817-73
Primary Type:
Respiratory
Generic Status:
Multi-Source
Route of Administration:
Inhalation
About:
Budesonide is a Respiratory drug manufactured by Cipla Usa Inc. and administered via the Inhalation route of administration. The J Code: J7626 is aligned to the drug Budesonide.